ISSN 1662-4009 (online)

ey0019.12-11 | Hyperlipidemia | ESPEYB19

12.11. Identification and evaluation of a lipid-lowering small compound in preclinical models and in a Phase I trial

H. Wang J, Zhao J, Yan C, Xi C, Wu C, Zhao J, Li F, Ding Y, Zhang R, Qi S, Li X, Liu C, Hou W, Chen H, Wang Y, Wu D, Chen K, Jiang H, Huang H, Liu

Cell Metabolism 2022;34(5):667-80.e6. doi: 10.1016/j.cmet.2022.03.006Brief Summary: In preclinical models and a phase 1 trial, a powerful new lipid small molecule was shown to act through a mechanism distinct from those of known hypolipidemic agents. Targeting HNF-1α may be a new therapeutic strategy.Comment: Familial hypercholesterolemia (FH) is the most common...

ey0019.10-8 | New paradigms | ESPEYB19

10.8. Insulin is expressed by enteroendocrine cells during human fetal development

A Egozi , D Llivichuzhca-Loja , BT McCourt , K Bahar Halpern , L Farack , X An , F Wang , K Chen , L Konnikova , S Itzkovitz

Nat Med. 2021 Dec;27(12):2104-2107. https://pubmed.ncbi.nlm.nih.gov/34887578/Brief Summary: This study used single-cell transcriptomic analyses to generate a cell atlas of the human fetal and neonatal small intestine. Notably, the authors identified a subset of fetal enteroendocrine K/L cells (named FIKL) that express high levels of insulin and other beta cell genes.T...

ey0017.11-7 | Body Weight and Appetite/Energy Regulation | ESPEYB17

11.7. Leptin mediates postprandial increases in body temperature through hypothalamus-adrenal medulla-adipose tissue crosstalk

RJ Perry , K Lyu , A Rabin-Court , J Dong , X Li , Y Yang , H Qing , A Wang , X Yang , GI Shulman

To read the full abstract: J Clin Invest 2020;130(4):2001–16.In this study, Perry et al used their well-established animal model of fasted rats to unravel how feeding induces hyperthermia and energy expenditure.They showed that intracerebroventricular injection of leptin normalized fasting induced low plasma epinephrine and norepinephrine levels and body temperat...

ey0016.1-5 | New Mechanisms | ESPEYB16

1.5. CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency

N Matharu , S Rattanasopha , S Tamura , L Maliskova , Y Wang , A Bernard , A Hardin , WL Eckalbar , C Vaisse , N Ahituv

To read the full abstract: Science 2019;363(6424).A wide range of human diseases result from haploinsufficiency, where gene expression is decreased as compared to normal conditions. Haploinsufficiency is a typical mechanism in autosomal dominant disorders. Rare mutations in Sim1 or Mc4r are models of haploinsufficiency causing severe early-onset obesity with hyperphagia...

ey0016.10-11 | (1) | ESPEYB16

10.11. Changes in diabetes medication regimens and glycemic control in adolescents and young adults with youth-onset type 2 diabetes: The SEARCH for diabetes in youth study

CA Pinto , JM Stafford , T Wang , RR Shankar , JM Lawrence , G Kim , C Pihoker , RB Jr D'Agostino , D Dabelea

Pediatr Diabetes. 2018 May 15. doi: 10.1111/pedi.12691There is a small but significant debate as to whether or not type 1 (T1D) and type 2 diabetes (T2D) are the same disease with albeit different course. It might therefore be prudent to include into a chapter on T1D a publication on T2D. This study aimed to describe recent medication patterns and changes in medication patterns and glycemic con...

ey0015.11-21 | Diet and the genes | ESPEYB15

11.21 Improving adherence to healthy dietary patterns, genetic risk, and long term weight gain: gene-diet interaction analysis in two prospective cohort studies

T Wang , Y Heianza , D Sun , T Huang , W Ma , EB Rimm , JE Manson , FB Hu , WC Willett , L Qi

To read the full abstract: BMJ. 2018 Jan 10;360:j5644On the basis of scientific evidence and dietary recommendations, several diet quality scores have been developed to evaluate the healthfulness of dietary patterns. Previous studies show that improvement in adherence to healthy dietary patterns is associated with less weight gain (2, 3, 4). But, until now, no study had assessed the interaction betwe...

ey0015.13-16 | Advances in the Diagnosis and Management of Congenital Hypothyroidism | ESPEYB15

13.16 Incidence of congenital hypothyroidism in China: data from the national newborn screening program, 2013-2015

K Deng , C He , J Zhu , J Liang , X Li , X Xie , P Yu , N Li , Q Li , Y Wang

To read the full abstract: J Pediatr Endocrinol Metab 2018; 31(6):601-608This article summarizes the findings of likely the largest program of neonatal congenital hypothyroidism (CH) screening in the world. This is a truly impressive effort. The overall incidence of CH was 1/2421, in line with other reports that also observed a relatively high incidence of CH in neonates born in Asia. However, a...

ey0015.15-12 | Obesity must be studied separately in men and women | ESPEYB15

15.12 TAp63 contributes to sexual dimorphism in POMC neuron functions and energy homeostasis

C Wang , Y He , P Xu , Y Yang , K Saito , Y Xia , X Yan , A Hinton Jr , C Yan , H Ding

To read the full abstract: Nature Communications 2018;9:1544Obesity prevalence is generally higher in women than in men, and there is also a sex difference in body fat distribution. Sex differences in obesity can be explained in part by the influence of gonadal steroids on body composition and appetite; however, behavioural, and socio-cultural factors may also play a role. Here is th...

ey0020.9-5 | Advances in Understanding Central Weight Regulation and Behaviour | ESPEYB20

9.5. A synaptic amplifier of hunger for regaining body weight in the hypothalamus

K Grzelka , H Wilhelms , S Dodt , ML Dreisow , JC Madara , SJ Walker , C Wu , D Wang , BB Lowell , H Fenselau

Brief summary: Grzelka et al. identified a hypothalamic circuit that regulates regain of body weight after weight loss.Body weight is one of the most regulated variables of our body, which is most likely due to the evolutionary history of times when access to food was scarce and volatile. Weight loss triggers a strong counterregulatory response. It increases the hunger drive and greatly increases the reward value of food, making it more difficul...

ey0021.5-9 | Novel Treatments | ESPEYB21

5.9. Safety and efficacy of denosumab in children with osteogenesis imperfecta-the first prospective comparative study

Liu Jiayi , Lin Xiaoyun , Sun Lei , Zhang Qian , Jiang Yan , Wang Ou , Xing Xiaoping , Xia Weibo , Li Mei

In brief: This 1-year, open-label, randomised controlled trial examined the effects and tolerability of denosumab, compared with zoledronic acid, on bone mineral density (BMD), spinal morphometry, and safety in a large cohort of children (n=84) with osteogenesis imperfecta. Treatment with denosumab increased BMD and improved spinal morphometry in children with OI, but was frequently associated with rebound hypercalcaemia (in 31%). This rebound hypercalcaemia could be alleviate...